The threat of mosquito-borne outbreaks of emerging viruses will be tackled by the newly-established Research Group for Emerging Viruses, Inflammation and Therapeutics.
By Suresh Mahalingam, Principal Research Leader, Institute for Glycomics As Zika fear rises, especially in the wake of the World Health Organization last night declaring a state of public health emergency, people are inevitably asking why we don’t have a vaccine to protect against the mosquito-borne virus. Zika is generally a mild illness, causing fever, […]